Report ID: SQMIG35H2181
Report ID:
SQMIG35H2181 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
62 |
Figures:
76
North America held a 34.6% market share. This is illuminated by the region's well-established healthcare facilities, the rising prevalence of brain tumors and malignancies, and the convenience of highly qualified neurosurgeons. The market for North America is primarily driven by the rising incidence of detailed disorders including brain tumors, most of which are malignant, and neurodegenerative diseases. Additionally, the market expansion in the area is being supported by the incidence of significant important players. Thus, the primary factors driving the market are the increasing number of minimally invasive neurosurgery procedures and the rising incidence of neurological diseases.
The Asia Pacific is projected to grow at the fastest rate of 7.6% CAGR in 2022, due to several factors, including a substantial patient population, increased medical tourism, rising government spending on healthcare, and the adoption of minimally invasive surgeries. Furthermore, because there are numerous people in this region suffering from brain cancer, Alzheimer's disease, and numerous other nervous system disorders, countries in this region are growing their exhaustive care units in hospitals as well as other ambulatory surgical units for the treatment of neurosurgeries. Accordingly, these elements are driving market growth in this area.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2181